Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2016 May-Jun;36(3):216-22.
doi: 10.5144/0256-4947.2016.216.

Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter study

Affiliations
Multicenter Study

Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter study

Gul R Yilmaz et al. Ann Saudi Med. 2016 May-Jun.

Abstract

Background: Knowing risk factors for colistin resistance is important since colistin is the only remaining choice for the treatment of infections caused by multi-drug resistant microorganisms.

Objective: Evaluate risk factors associated with infection by colistin-resistant microorganisms.

Design: Retrospective study.

Setting: Tertiary healthcare centers.

Patients and methods: An e-mail including the title and purpose of the study was sent to 1500 infec.tious disease specialists via a scientific and social web portal named "infeksiyon dunyasi (infection world)". Demographic and clinical data was requested from respondents.

Main outcome measure(s): Colistin-resistance.

Results: Eighteen infectious disease specialists from twelve tertiary care centers responded to the invitation data was collected on 165 patients, 56 cases (39.9%) and 109 (66.0%) age- and sex-matched controls. The colistin-resistant microorganisms isolated from cases were 29 Acinetobacter baumannii (51.8%), 18 Pseudomonas aeruginosa (32.1%) and 9 Klebsiella spp. Colistin, carbapenem, and quinolone use in the last three months were risk factors for colistin resistance in the univariate analysis. Previous quinolone use in the last three months (P=.003; RR:3.2; 95% Ci:1.5-6,7) and previous colistin use in the last three months (P=.001; RR: 3.6; 95% CI: 1.63-7.99) were significant risk factors in the multivariate analysis.

Conclusion: Clinicians should limit the use of quinolones and remain aware of the possibility of resistance developing during colistin use.

Limitations: The lack of a heteroresistance analysis on the isolates. no data on use of a loading dose or the use of colistin in combination.

PubMed Disclaimer

Conflict of interest statement

Transparency declaration

No conflict of interest.

References

    1. Kontopidou F, Plachouras D, Papadomichelakis E, Koukos G, Galani I, Poulakou G, et al. Colonization and infection by colistin-resistant gram-negative bacteria in a cohort of critically ill patients. Clin Microbiol Infect. 2011;17:9–11. - PubMed
    1. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, et al. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis. 2006;6:589–601. - PubMed
    1. Matthaiou DK, Michalopoulos A, Rafailidis PI, Karageorgopoulos DE, Papaioannou V, Ntani G, et al. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med. 2008;36:807–11. - PubMed
    1. Landman D, Bratu S, Alam M, Quale J. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B. J Antimicrob Chemother. 2005;55:954–7. - PubMed
    1. Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassopoulou P, Michalopoulos A. Outcome of infections due to pandrugresistant (PDR) gram-negative bacteria. BMC Infect Dis. 2005;5:24. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources